Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
February-2017 Volume 13 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2017 Volume 13 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Autophagy impacts on oxaliplatin-induced hepatocarcinoma apoptosis via the IL-17/IL-17R-JAK2/STAT3 signaling pathway

  • Authors:
    • Jinghua Wu
    • Jiapei Guo
    • Qing Cao
    • Yi Wang
    • Junmao Chen
    • Zhigang Wang
    • Zhiyong Yuan
  • View Affiliations / Copyright

    Affiliations: Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300000, P.R. China, Clinical Laboratory, Affiliated Hospital of North China University of Science and Technology, Tangshan, Hebei 063000, P.R. China, Clinical Laboratory, Hebei Medical University Second Hospital, Shijiazhuang, Hebei 050000, P.R. China, Clinical Laboratory, Tangshan Fengrun Region Second People's Hospital, Tangshan, Hebei 063000, P.R. China
  • Pages: 770-776
    |
    Published online on: December 8, 2016
       https://doi.org/10.3892/ol.2016.5476
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The interleukin (IL)-17/IL-17 receptor (IL-17R) complex has been shown to be important for the regulation of inflammation; however, its role in the regulation of tumor processes has recently emerged as a research focus. The present study demonstrated that oxaliplatin was able to increase the levels of IL‑17/IL‑17R in hepatocellular carcinoma (HCC) patients and cells lines, and that it had important roles in reducing the susceptibility of the cells to oxaliplatin‑induced apoptosis. Furthermore, the expression of autophagy‑related proteins was induced by IL-17/IL-17R and autophagy was shown to induce resistance to oxaliplatin in HCC. In addition, the janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) pathway was shown to be an important pathway in the induction of autophagy in response to oxaliplatin. Autopjhagy was inhibited by 3-methyladenine and JAK2/STAT3 signaling was blocked by AG490, which induced apoptosis in SMMC7721 cells treated with oxaliplatin. The results of the present study may help to elucidate the mechanism underlying the role of IL‑17/IL‑17R‑induced autophagy in the chemoresistance of HCC, as well as help to establish and develop measures to overcome chemoresistance in HCC.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Zhao Y, Wang Q, Deng X, Shi P and Wang Z: Quantitative assessment of the association between GSTP1 gene Ile105Val polymorphism and susceptibility to hepatocellular carcinoma. Tumor Biol. 34:2121–2126. 2013. View Article : Google Scholar

2 

Louaf S, Boige V, Ducreux M, Bonyhay L, Mansourbakht T, de Baere T, Asnacios A, Hannoun L, Poynard T and Taïeb J: Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): Results of a phase II study. Cancer. 109:1384–1390. 2007. View Article : Google Scholar : PubMed/NCBI

3 

Sun HQ, Zhang JY, Zhang H, Zou ZS, Wang FS and Jia JH: Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis. J Viral Hepat. 19:396–403. 2012. View Article : Google Scholar : PubMed/NCBI

4 

Du H, Yang W, Chen L, Shi M, Seewoo V, Wang J, Lin A, Liu Z and Qiu W: Role of autophagy in resistance to oxaliplatin in hepatocellular carcinoma cells. Oncol Rep. 27:143–150. 2012.PubMed/NCBI

5 

Shen F and Gaffen SL: Structure-function relationships in the IL-17 receptor: Implications for signal transduction and therapy. Cytokine. 41:92–104. 2008. View Article : Google Scholar : PubMed/NCBI

6 

Gaffen SL: Recent advances in the IL-17 cytokine family. Curr Opin Immunol. 23:613–619. 2011. View Article : Google Scholar : PubMed/NCBI

7 

Ma Y, Aymeric L, Locher C, Mattarollo SR, Delahaye NF, Pereira P, Boucontet L, Apetoh L, Ghiringhelli F, Casares N, et al: Contribution of IL-17-producing gamma delta T cells to the ecacy of anticancer chemotherapy. J Exp Med. 208:491–503. 2011. View Article : Google Scholar : PubMed/NCBI

8 

Lv L, Pan K, Li XD, She KL, Zhao JJ, Wang W, Chen JG, Chen YB, Yun JP and Xia JC: The accumulation and prognosis value of tumor infiltrating IL-17 producing cells in esophageal squamous cell carcinoma. PLoS One. 6:e182192011. View Article : Google Scholar : PubMed/NCBI

9 

Li Q, Han Y, Fei G, Guo Z, Ren T and Liu Z: IL-17 promoted metastasis of non-small-cell lung cancer cells. Immunol Lett. 148:144–150. 2012. View Article : Google Scholar : PubMed/NCBI

10 

Lemancewicz D, Bolkun L, Jablonska E, Czeczuga-Semeniuk E, Kostur A, Kloczko J and Dzieciol J: The role of interleukin-17A and interleukin-17E in multiple myeloma patients. Med Sci Monit. 18:BR54–BR59. 2012. View Article : Google Scholar : PubMed/NCBI

11 

Droeser RA, Güth U, Eppenberger-Castori S, Stadlmann S, Hirt C, Terracciano L and Singer G: High IL-17-positive tumor immune cell infiltretion is indicative for chemosensitivity of ovarian carcinoma. J Cancer Res Clin Oncol. 139:1295–1302. 2013. View Article : Google Scholar : PubMed/NCBI

12 

Maitra A, Shen F, Hanel W, Mossman K, Tocker J, Swart D and Gaffen SL: Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression. Proc Nat Acad Sci USA. 104:7506–7511. 2007. View Article : Google Scholar : PubMed/NCBI

13 

Korn T: Th17 cells: Effector T cells with inflammatory properties. Semin Immunol. 19:362–371. 2007. View Article : Google Scholar : PubMed/NCBI

14 

Gaffen SL: Structure and signaling in the IL-17 receptor family. Nat Rev Immunol. 9:556–567. 2009. View Article : Google Scholar : PubMed/NCBI

15 

Okinaga T, Ariyoshi W and Akifusa S: Essential role of JAK/STAT pathway in the induction of cell cycle arrest in macrophages infected with periodontopathic bacterium Aggregatibacter actinomycetemcomitans. Med Microbiol Immunol. 202:167–74. 2013. View Article : Google Scholar : PubMed/NCBI

16 

Chen Y, Jiao B, Yao M, Shi X, Zheng Z, Li S and Chen L: ISG12a inhibits HCV replication and potentiates the anti-HCV activity of IFN-α through activation of the Jak/STAT signaling pathway independent of autophagy and apoptosis. Virus Res. 10:S0168–S01702. 2016.

17 

Gu FM, Li QL, Gao Q, Jiang JH, Zhu K, Huang XY, Pan JF, Yan J, Hu JH, Wang Z, et al: IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma. Mol Cancer. 10:1502011. View Article : Google Scholar : PubMed/NCBI

18 

Xu Y, An Y, Wang Y, Zhang C, Zhang H, Huang C, Jiang H, Wang X and Li X: miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells. Oncol Rep. 29:2019–2024. 2013.PubMed/NCBI

19 

Harris SJ, Ciuclan L, Finan PM, Wymann MP, Walker C, Westwick J, Ward SG and Thomas MJ: Genetic ablation of PI3Kγ results in defective IL-17RA signalling in T lymphocytes and increased IL-17 levels. Eur J Immunol. 42:3394–3404. 2012. View Article : Google Scholar : PubMed/NCBI

20 

Murugaiyan G and Saha B: Protumor vs antitumor functions of IL-17. J Immunol. 183:4169–4175. 2009. View Article : Google Scholar : PubMed/NCBI

21 

Fortmüller K, Alt K, Gierschner D, Wolf P, Baum V, Freudenberg N, Wetterauer U, Elsässer-Beile U and Bühler P: Effective targeting of prostate cancer by lymphocytes redirected by a PSMAxCD3 bispecific single-chain diabody. Prostate. 71:588–596. 2011. View Article : Google Scholar : PubMed/NCBI

22 

Tesmer LA, Lundy SK, Sarkar S and Fox DA: Th17 cells in human disease. Immunol Rev. 223:87–113. 2008. View Article : Google Scholar : PubMed/NCBI

23 

Martin F, Apetoh L and Ghiringhelli F: Controversies on the role of Th17 in cancer: A TGF-β-dependent immunosuppressive activity? Trends Mol Med. 18:742–749. 2012. View Article : Google Scholar : PubMed/NCBI

24 

Anilkumar U and Prehn JHM: Anti-apoptotic BCL-2 family proteins in acute neural injury. Front Cell Neurosci. 30:2812014.

25 

Xu Y and Lv SX: The effect of JAK2 knockout on inhibition of liver tumor growth by inducing apoptosis, autophagy and anti-proliferation via STATs and PI3K/AKT signaling pathways. Biomed Pharmacother. 84:1202–1212. 2016. View Article : Google Scholar : PubMed/NCBI

26 

Tan YQ, Zhang J and Zhou G: Autophagy and its implication in human oral diseases. Autophagy. 20:02016.

27 

Cui J, Gong Z and Shen HM: The role of autophagy in liver cancer: Molecular mechanisms and potential therapeutic targets. Biochim Biophys Acta. 1836:15–26. 2013.PubMed/NCBI

28 

Liu D, Yang Y, Liu Q and Wang J: Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells. Med Oncol. 28:105–111. 2011. View Article : Google Scholar : PubMed/NCBI

29 

Golden EB, Cho HY, Jahanian A, Hofman FM, Louie SG, Schönthal AH and Chen TC: Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy. Neurosurg Focus. 37:E122014. View Article : Google Scholar : PubMed/NCBI

30 

Wu W, Li W, Zhou Y and Zhang C: Inhibition of beclin1 affects the chemotherapeutic sensitivity of osteosarcoma. Int J Clin Exp Pathol. 7:7114–7122. 2014.PubMed/NCBI

31 

Moore N, Houghton J and Lyle S: Slow-cycling therapy-resistant cancer cells. Stem Cells Dev. 21:1822–1830. 2012. View Article : Google Scholar : PubMed/NCBI

32 

Jungwirth U, Xanthos DN, Gojo J, Bytzek AK, Körner W, Heffeter P, Abramkin SA, Jakupec MA, Hartinger CG, Windberger U, et al: Anticancer activity of methyl-substituted oxaliplatin analogs. Mol Pharmacol. 81:719–728. 2012. View Article : Google Scholar : PubMed/NCBI

33 

Shpilka T, Weidberg H, Pietrokovski S and Elazar Z: Atg8: An autophagy-related ubiquitin-like protein family. Genome Biol. 12:2262011. View Article : Google Scholar : PubMed/NCBI

34 

Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y and Yoshimori T: LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19:5720–5728. 2000. View Article : Google Scholar : PubMed/NCBI

35 

Zhou YY, Li Y, Jiang WQ and Zhou LF: MAPK/JNK signalling: a potential autophagy regulation pathway. Biosci Rep. 35:e01992015.

36 

Xiong H, Zhang ZG, Tian XQ, Sun DF, Liang QC, Zhang YJ, Lu R, Chen YX and Fang JY: Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. Neoplasia. 10:287–297. 2008. View Article : Google Scholar : PubMed/NCBI

37 

Yuan L, Wei S, Wang J and Liu X: Isoorientin induces apoptosis and autophagy simultaneously by reactive oxygen species (ROS)-related p53, PI3K/Akt, JNK, and p38 signaling pathways in HepG2 cancer cells. J Agric Food Chem. 62:5390–5400. 2014. View Article : Google Scholar : PubMed/NCBI

38 

Jaber N, Dou Z, Chen JS, Catanzaro J, Jiang YP, Ballou LM, Selinger E, Ouyang X, Lin RZ, Zhang J and Zong WX: Class III PI3K Vps34 plays an essential role in autophagy and in heart and liver function. Proc Natl Acad Sci USA. 109:2003–2008. 2012. View Article : Google Scholar : PubMed/NCBI

39 

Zhang DM, Liu JS, Deng LJ, Chen MF, Yiu A, Cao HH, Tian HY, Fung KP, Kurihara H, Pan JX and Ye WC: Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway. Carcinogenesis. 34:1331–1342. 2013. View Article : Google Scholar : PubMed/NCBI

40 

Bai R, Ding T, Zhao J, Liu S, Zhang L, Lan X, Yu Y and Yin L: The effect of PI3K inhibitor LY294002 and gemcitabine hydrochloride combined with ionizing radiation on the formation of vasculogenic mimicry of Panc-1 cells in vitro and in vivo. Neoplasma. 63:80–92. 2016. View Article : Google Scholar : PubMed/NCBI

41 

Li J, Yang D, Wang W, Piao S, Zhou J, Saiyin W, Zheng C, Sun H and Li Y: Inhibition of autophagy by 3-MA enhances IL-24- induced apoptosis in human oral squamous cell carcinoma cells. J Exp Clin Cancer Res. 34:972015. View Article : Google Scholar : PubMed/NCBI

42 

Yamada H: Th17 cells in human rheumatoid arthritis. Nihon Rinsho Meneki Gakkai Kaishi. 32:249–255. 2009.(In Japanese). View Article : Google Scholar : PubMed/NCBI

43 

Zou W and Restifo NP: T(H)17 cells in tumour immunity and immunotherapy. Nat Rev Immunol. 10:248–256. 2010. View Article : Google Scholar : PubMed/NCBI

44 

Novatchkova M, Leibbrandt A, Werzowa J, Neubüser A and Eisenhaberemail F: The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem Sci. 28:226–229. 2003. View Article : Google Scholar : PubMed/NCBI

45 

Schraml BU, Hildner K, Ise W, Lee WL, Smith WA, Solomon B, Sahota G, Sim J, Mukasa R, Cemerski S, et al: The AP-1 transcription factor Batf controls T(H)17 differentiation. Nature. 460:405–409. 2009.PubMed/NCBI

46 

Zhang X, Weng W, Xu W, Wang Y, Yu W, Tang X, Ma L, Pan Q, Wang J and Sun F: Prognostic significance of interleukin 17 in cancer: A meta-analysis. Int J Clin Exp Med. 7:3258–3269. 2014.PubMed/NCBI

47 

Zhang JP, Yan J, Xu J, Pang XH, Chen MS, Li L, Wu C, Li SP and Zheng L: Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol. 50:980–989. 2009. View Article : Google Scholar : PubMed/NCBI

48 

Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S, Huang E, Finlayson E, Simeone D, Welling TH, et al: Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood. 114:1141–1149. 2009. View Article : Google Scholar : PubMed/NCBI

49 

Hambright HG and Ghosh R: Autophagy: In the cROSshairs of cancer. Biochem Pharmacol. (In Press). PubMed/NCBI

50 

Marin JJ, Lozano E and Perez MJ: Lack of mitochondrial DNA impairs chemical hypoxia-induced autophagy in liver tumor cells through ROS-AMPK-ULK1 signaling dysregulation independently of HIF-1α. Free Radic Biol Med. 101:71–84. 2016. View Article : Google Scholar : PubMed/NCBI

51 

Weiland A, Roswall P, Hatzihristidis TC, Pietras K, Ostman A and Strell C: Fibroblast-dependependent regulation of the stem cell properties of cancer cells. Neoplasma. 59:719–727. 2012. View Article : Google Scholar : PubMed/NCBI

52 

Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, Thomas-Tikhonenko A and Thompson CB: Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest. 117:326–336. 2007. View Article : Google Scholar : PubMed/NCBI

53 

Yuan J, Zhang Y, Sheng Y, Fu X, Cheng H and Zhou R: MYBL2 guides autophagy suppressor VDAC2 in the developing ovary to inhibit autophagy through a complex of VDAC2-BECN1-BCL2L1 in mammals. Autophagy. 11:1081–1098. 2015. View Article : Google Scholar : PubMed/NCBI

54 

Xu Y, Li Z, Yin Y, Lan H, Wang J, Zhao J, Feng J, Li Y and Zhang W: Ghrelin inhibits the differentiation of T helper 17 cells through mTOR/STAT3 signaling pathway. PLoS One. 10:e01170812015. View Article : Google Scholar : PubMed/NCBI

55 

Li P, Shi J, He Q, Hu Q, Wang YY, Zhang LJ, Chan WT and Chen WX: Streptococcus pneumoniae Induces autophagy through the inhibition of the PI3K-I/Akt/mTOR pathway and ROS hypergeneration in A549 cells. PLoS One. 10:e01227532015. View Article : Google Scholar : PubMed/NCBI

56 

Aveleira CA, Botelho M, Carmo-Silva S, Pascoal JF, Ferreira-Marques M, Nóbrega C, Cortes L, Valero J, Sousa-Ferreira L, Álvaro AR, et al: Neuropeptide Y stimulates autophagy in hypothalamic neurons. Proc Natl Acad Sci USA. 112:E1642–E1651. 2015. View Article : Google Scholar : PubMed/NCBI

57 

Wang P, Guo QS, Wang ZW and Qian HX: HBx induces HepG-2 cells autophagy through PI3K/Akt-mTOR pathway. Mol Cell Biochem. 372:161–168. 2013. View Article : Google Scholar : PubMed/NCBI

58 

Huang F, Kao CY, Wachi S, Thai P, Ryu J and Wu R: Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-κappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells. J Immunol. 179:6504–6513. 2007. View Article : Google Scholar : PubMed/NCBI

59 

Sun X, Zhang J, Hou Z, Han Q, Zhang C and Tian Z: miR-146a is directly regulated by STAT3 in human hepatocellular carcinoma cells and involved in anti-tumor immune suppression. Cell Cycle. 14:243–252. 2015. View Article : Google Scholar : PubMed/NCBI

60 

Cross-Knorr S, Lu S, Perez K, Guevara S, Brilliant K, Pisano C, Quesenberry PJ, Resnick MB and Chatterjee D: RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients. BMC Cancer. 13:4632013. View Article : Google Scholar : PubMed/NCBI

61 

Kim KW, Cho ML, Park MK, Yoon CH, Park SH, Lee SH and Kim HY: Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor kappaB-dependent pathway in patients with rheumatoid arthritis. Arthritis Res Ther. 7:R139–R148. 2005. View Article : Google Scholar : PubMed/NCBI

62 

Huang C, Yang G, Jiang T, Huang K, Cao J and Qiu Z: Effects of IL-6 and AG490 on regulation of Stat3 signaling pathway and invasion of human pancreatic cancer cells in vitro. J Exp Clin Cancer Res. 29:512010. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wu J, Guo J, Cao Q, Wang Y, Chen J, Wang Z and Yuan Z: Autophagy impacts on oxaliplatin-induced hepatocarcinoma apoptosis via the IL-17/IL-17R-JAK2/STAT3 signaling pathway. Oncol Lett 13: 770-776, 2017.
APA
Wu, J., Guo, J., Cao, Q., Wang, Y., Chen, J., Wang, Z., & Yuan, Z. (2017). Autophagy impacts on oxaliplatin-induced hepatocarcinoma apoptosis via the IL-17/IL-17R-JAK2/STAT3 signaling pathway. Oncology Letters, 13, 770-776. https://doi.org/10.3892/ol.2016.5476
MLA
Wu, J., Guo, J., Cao, Q., Wang, Y., Chen, J., Wang, Z., Yuan, Z."Autophagy impacts on oxaliplatin-induced hepatocarcinoma apoptosis via the IL-17/IL-17R-JAK2/STAT3 signaling pathway". Oncology Letters 13.2 (2017): 770-776.
Chicago
Wu, J., Guo, J., Cao, Q., Wang, Y., Chen, J., Wang, Z., Yuan, Z."Autophagy impacts on oxaliplatin-induced hepatocarcinoma apoptosis via the IL-17/IL-17R-JAK2/STAT3 signaling pathway". Oncology Letters 13, no. 2 (2017): 770-776. https://doi.org/10.3892/ol.2016.5476
Copy and paste a formatted citation
x
Spandidos Publications style
Wu J, Guo J, Cao Q, Wang Y, Chen J, Wang Z and Yuan Z: Autophagy impacts on oxaliplatin-induced hepatocarcinoma apoptosis via the IL-17/IL-17R-JAK2/STAT3 signaling pathway. Oncol Lett 13: 770-776, 2017.
APA
Wu, J., Guo, J., Cao, Q., Wang, Y., Chen, J., Wang, Z., & Yuan, Z. (2017). Autophagy impacts on oxaliplatin-induced hepatocarcinoma apoptosis via the IL-17/IL-17R-JAK2/STAT3 signaling pathway. Oncology Letters, 13, 770-776. https://doi.org/10.3892/ol.2016.5476
MLA
Wu, J., Guo, J., Cao, Q., Wang, Y., Chen, J., Wang, Z., Yuan, Z."Autophagy impacts on oxaliplatin-induced hepatocarcinoma apoptosis via the IL-17/IL-17R-JAK2/STAT3 signaling pathway". Oncology Letters 13.2 (2017): 770-776.
Chicago
Wu, J., Guo, J., Cao, Q., Wang, Y., Chen, J., Wang, Z., Yuan, Z."Autophagy impacts on oxaliplatin-induced hepatocarcinoma apoptosis via the IL-17/IL-17R-JAK2/STAT3 signaling pathway". Oncology Letters 13, no. 2 (2017): 770-776. https://doi.org/10.3892/ol.2016.5476
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team